Renascience Revenue

In the fiscal year ending March 31, 2025, Renascience had annual revenue of 132.00M JPY, down -31.96%. Renascience had revenue of 67.00M in the quarter ending March 31, 2025, a decrease of -9.46%.

Revenue

132.00M

Revenue Growth

-31.96%

P/S Ratio

280.72

Revenue / Employee

44.00M

Employees

Market Cap

37.05B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	132.00M	-62.00M	-31.96%
Mar 31, 2024	194.00M	94.00M	94.00%
Mar 31, 2023	100.00M	-39.00M	-28.06%
Mar 31, 2022	139.00M	-70.00M	-33.49%
Mar 31, 2021	209.00M	137.00M	190.28%
Mar 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Takeda Pharmaceutical Company	4,581.55B
Daiichi Sankyo Company	1,886.26B
HOYA Corporation	866.03B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Shionogi &	438.27B

Revenue Rankings